A value deficit and potential consumer value proposition.
At some point, something new in a particular market becomes a development and, occasionally, if the development has sufficient traction, it can reshape a market. This discussion suggests Amazon’s presence in the pharma market could potentially fit that picture for the part of the market that falls below specialty products and orphan conditions.
Amazon’s healthcare business focuses on what might be called the transactional dimension of the healthcare system. It targets the time, scheduling, and financial burden patients experience. Its underlying assumption is that this burden is increasing and by leveraging its core competency in IT and operations, it can make a business by leaning into logistics to produce superior customer value.
Two business units comprise Amazon’s healthcare business: Amazon Pharmacy and One Medical, the latter being brick-and-mortar facilities for in-person visits in roughly 240 locations, plus telehealth, video conferences, and on-demand virtual care.
While it’s reasonable to be skeptical about the brick-and-mortar business having a defining market impact, Amazon’s wager is that its pharmacy combined with virtual care options can create an ecosystem attracting growing numbers of patients because of the healthcare system’s value deficit and Amazon’s ability to deliver consumer value.
Drawing on trade press and additional discussion, consumer value is produced from the integration of four value drivers. Amazon’s logistical strengths are embedded in each of these value drivers:
Given the prevalence of deductibles, provider shortages, cumbersome provider phone systems, retail pharmacy waiting times, and pharmacy closures, Amazon has designed these four value drivers to improve the consumer experience in the pharmaceutical market.
From different angles, Blue Shield of California and Ely Lilly have each adopted strategic relationships with Amazon Health. This points to an element of the gig economy manufacturers can assume when evaluating how the Amazon system can benefit product growth—a different set of leverage points brands can lean into based on priorities and issues that vary by product.
Rather than seeing Amazon Health as an innovation at the fringes of the market, brand planning would be sell-served determining if the Amazon factor can add to overall strategy or if it does not apply.
Ira Studin, PhD, is President, Stellar Managed Care Consulting. He can be reached at istudin@stellarmc.com.